Wal-Mart’s UK Arm Discovers Horse DNA and 4 Dow Movers to Follow

Johnson & Johnson (NYSE:JNJ): Current price $75.92

The company has advised physicians outside the United States to cease the use of its Adept hip implant following a higher-than-expected failure rate, says Bloomberg. A United Kingdom database discovered that 12 percent of patients subsequently required a repeat surgery to fix the implant which hasn’t been sold since 2011. Around 7,500 of the hips were distributed in 21 countries other than the United States.